Back to Authors

Friedrich, Patricia F.

https://orcid.org/0000-0002-6143-9784

Mayo Clinic

Mayo Clinic

Citations 22

Cell lineage in vascularized bone transplantation
Willems, Wouter , Larsen, Mikko , Friedrich, Patricia F. , Willems, Wouter F, Bishop, Allen T.

Microsurgery | August 27, 2013 | Volume: 34 | Issue: 1 | Pages: 37-43

10.1002/micr.22147 Get It

MK-801 Attenuates Capillary Bed Compression and Hypoperfusion following Incomplete Focal Cerebral Ischemia
Meyer, Fredric B. , Friedrich, Patricia F. , Anderson, Robert E.

Journal of Cerebral Blood Flow & Metabolism | April 8, 2011 | Volume: 10 | Issue: 6 | Pages: 895-902

10.1038/jcbfm.1990.146 Get It

The effects of the N-methyl-d-aspartate (NMDA) antagonist MK-801 on capillary beds and CBF following 1 h of transient incomplete focal cerebral ischemia were studied by examining 133 Xe CBF, capillary diameter, and area of perfused vasculature. Capillary diameter increased from a control of 5.24 ± 0.37 to 8.62 ± 0.57 μm (p < 0.001) and area of perfused vasculature from 20,943 ± 1,151 to 30,442 ± 1,691 μm 2 /×10 magnification field (p < 0.001) with MK-801 1.0 mg/kg administered 30 min prior to ischemia. After flow restoration in control animals, there was a relative hypoperfusion with eventual normalization of CBF over 60 min. Alternatively, in MK-801 1.0 mg/kg animals, there was rapid normalization of CBF upon flow restoration without the postischemic hypoperfusion observed in controls. On histological analysis, there was consistently less neuronal edema in MK-801-treated animals. These results support the hypothesis that hypoperfusion following incomplete focal cerebral ischemia may be due in part to NMDA-mediated cellular edema with subsequent extravascular capillary bed compression.